CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
94.66
-0.63 (-0.66%)
At close: Sep 11, 2026, 4:00 PM EDT
94.55
-0.11 (-0.12%)
After-hours: Sep 11, 2026, 7:58 PM EDT

CVS Health Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Strong Buy" and an average price target of $116.28. The average 1-year stock price forecast is 22.84% higher than the current stock price, while the lowest is $103 (+8.81%) and the highest is $148 (+56.35%).

Price Target: $116.28 (+22.84%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$103$116.28$116$148
Change+8.81%+22.84%+22.54%+56.35%

Analyst Ratings

The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy181818181818
Buy766666
Hold344433
Sell000000
Strong Sell000000
Total282828282727

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Maintains
$123
BuyMaintains$123+29.94%Sep 10, 2026
Bernstein
Bernstein
Buy
Reiterates
$106
BuyReiterates$106+11.98%Sep 9, 2026
UBS
UBS
Buy
Reiterates
$126$118
BuyReiterates$126$118+24.66%Sep 3, 2026
Jefferies
Jefferies
Buy
Maintains
$120
BuyMaintains$120+26.77%Aug 31, 2026
TD Cowen
TD Cowen
Buy
Maintains
$110
BuyMaintains$110+16.21%Aug 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
417.18B
from 399.83B
Increased by 4.34%
Revenue Next Year
428.49B
from 417.18B
Increased by 2.71%
EPS This Year
7.97
from 6.75
Increased by 18.09%
EPS Next Year
8.51
from 7.97
Increased by 6.79%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
290.91B321.63B356.62B370.66B399.83B417.18B
Revenue Growth
8.59%10.56%10.88%3.94%7.87%4.34%
Gross Profit
50.92B53.66B53.28B49.25B53.13B59.54B
Gross Margin
17.50%16.69%14.94%13.29%13.29%14.27%
Operating Income
14.16B15.74B14.07B8.02B10.02B16.75B
Net Income
8.00B4.31B8.34B4.61B1.77B8.88B
EPS
----6.757.97
EPS Growth
----24.54%18.09%
Forward PE
12.8810.679.397.7711.5411.88
Dividend / Share
2.002.202.422.662.662.66
Dividend Growth
-10.00%10.00%9.92%--0.01%
Free Cash Flow
14.78B11.94B11.08B6.91B5.93B9.75B
No. Analysts
-----20
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High423.3B
Avg417.2B
Low414.2B

Revenue Growth

Revenue Growth202620272028
High
5.9%
Avg
4.3%
Low
3.6%

EPS Forecast

EPS202620272028
High8.15
Avg7.97
Low7.37

EPS Growth

EPS Growth202620272028
High
20.8%
Avg
18.1%
Low
9.2%